ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Clinical trials for ADVANCED CCNE1-AMPLIFIED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CCNE1-AMPLIFIED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED CCNE1-AMPLIFIED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug GVV858 shows promise in early trial for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study tests a new drug, GVV858, in people with advanced hormone receptor-positive, HER2-negative breast cancer and other solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it works better when given alone or with hormone t…
Matched conditions: ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug combo aims to control advanced breast cancer
Disease control Recruiting nowThis study tests an experimental drug called ECI830, alone or with other cancer drugs (ribociclib and fulvestrant), in people with advanced hormone receptor-positive, HER2-negative breast cancer or certain solid tumors. The goal is to find safe doses and see if the combination ca…
Matched conditions: ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 04, 2026 16:23 UTC